| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8680 |
| Human Intestinal Absorption | HIA+ | 0.9916 |
| Caco-2 Permeability | Caco2+ | 0.8191 |
| P-glycoprotein Substrate | Non-substrate | 0.6662 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.5839 |
| Non-inhibitor | 0.7595 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8621 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8622 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7789 |
| CYP450 2D6 Substrate | Non-substrate | 0.8620 |
| CYP450 3A4 Substrate | Non-substrate | 0.6318 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5634 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8069 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9531 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5858 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8001 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5251 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9405 |
| Non-inhibitor | 0.9661 |
| AMES Toxicity | Non AMES toxic | 0.7626 |
| Carcinogens | Non-carcinogens | 0.8660 |
| Fish Toxicity | High FHMT | 0.9903 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9908 |
| Honey Bee Toxicity | High HBT | 0.8173 |
| Biodegradation | Ready biodegradable | 0.6356 |
| Acute Oral Toxicity | III | 0.8241 |
| Carcinogenicity (Three-class) | Non-required | 0.5678 |